(Total Views: 663)
Posted On: 04/10/2020 5:08:42 PM
Post# of 154001
Quote:
Perhaps, because leronlimab is too good and thus is too dangerous to too many powerful interests.
Perhaps, but we're talking about national and international media... and preventing unnecessary deaths... if I were interviewing Dr. Pourhassan, I would ask him about it, and hope someone does down the road...
I realize there are plenty of competitors, among them some large ones ... at least 30 others according to Forbes with treatments ... as well as other "powerful interests" but I cannot buy into such conspiracy theories... peoples' lives are at immediate stake.
https://www.forbes.com/sites/giacomotognini/2...0da395899f
(0)
(0)
